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We  recently  described  a  new  precipitating  antigen,  rho,  in  the  blood  of 
patients with rubella infection, and in the fluids from rubella virus-infected cell 
cultures (1). The antigen was detected by gel diffusion using antisera from rab- 
bits which had been hyperimmunized with fractions of purified rubella virus. 
Although,  on the basis of these and other preliminary experiments it seemed 
likely that rho was a  structural protein of the virus,  as the  sensitivity of the 
assay was  increased  it  became  clear  that  the  antigen  was  not  restricted  to 
rubella. Not only did we find it in sera from normal newborn infants but it was 
also detected in sera collected from populations  living in remote areas where 
rubella had not penetrated, as shown by a lack of hemagglutination-inhibifing 
(HAI)  1 antibodies to the virus in all age groups3 Furthermore, we found that 
rho  titers  were elevated in  situations  and  diseases  other  than  rubella.  These 
several pieces of evidence led to the conclusion that rho was an antigenic de- 
terminant of a normal plasma constituent which, like the acute phase proteins 
(2), increases in concentration following certain stresses. 
The  origin  of the  antigen  in  rubella virus-infected cultures  was less clear, 
however, since rho released into the medium had about the same titer as rubella- 
specific antigens,  and it could not be demonstrated in uninfected cells.  A pos- 
sible explanation seemed to be that rubella virus coded for a determinant which 
was antigenically indistinguishable  from that  of  a  normal serum component. 
This  report  compares  the  properties  of  rho  obtained  from  the  two  sources 
(human sera and rubella-infected tissue culture media) and presents other data 
bearing on the genetic origin of the antigen. Our findings support the hypothesis 
that rho is a newly recognized acute phase protein, inducible both in vivo and in 
* This work was supported by U. S. Public Health Service  Grant CC-00532. 
:~ Recipient of Eli Lilly International Fellowship. Present address: Institut Pasteur  du 
Brabant, Bruxelles,  Belgium. 
1Abbrevlations  used  in  this  paper:  CRP,  C-reactive  protein;  HAI,  hemagglutination 
inhibiting. 
2 We are grateful to Dr. Francis L. Black, Yale University School of Medicine, for providing 
samples from his collections of sera from isolated Indian tribes in Brazil. 
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vitro  by  rubella  virus  infection,  and  by  other  as  yet  unidentified  factors  in 
pregnancy  and rheumatoid  arthritis. 
Materials  and Methods 
Rho Antigen.--The  standard antigen was a  200-fold Aquacide  (Calbiochem, San Diego, 
Calif.) concentrate of fluids from Veto monkey kidney cells grown in roller bottles and infected 
with the ~[herien wild-type strain of rubella virus isolated in our laboratory in 1965  (3). The 
medium  consisted  of  5%  kaolin-absorbed  fetal  calf  serum  in  Eagle's  minimum essential 
medium, containing 100 U  of penicillin, 100/~g streptomycin, and  10 U  of Mycostatin/ml. 
Details of cell and virus propagation have been described previously (4). 
Rho Hyperimmune Rabbit  Serum.--A suspension of rubella virus purified according to the 
method of Liebhaber and  Gross  (3)  was degraded  with 0.5%  Nonidet P-40 in Tris buffer 
(0.01 M Tris, pH 7.2, 0.1 M NaC1) containing 0.01 M  MgC12. After 15 min at room tempera- 
ture, the products of the reaction were separated by equilibrium density gradient centrifuga- 
tion in 15-65% (wt/wt) sucrose gradients for 24 h at 40,000 rpm in an SW 41 rotor at 4°C. 
The peak of UV-absorbing material banding at a solution density of 1.25 g/ml was collected 
and dialyzed overnight against Tris bufferfl 
Equal volumes of antigen suspension and complete Freund's adjuvant were  thoroughly 
emulsified and injected intramuscularly into rabbits. The animals were thereafter inoculated 
at monthly intervals in the same maimer and were exsanguinated 10 days after the third injec- 
tion. Sera were absorbed with lyophilized calf serum and with sonicated Vero cells before use. 
The serum pool contained anti-iota  and trace amounts of anti-theta  rubella precipitating anti- 
bodies (5) as well as antibodies against rho. 
Immunodiffusion.--Tests  were done on 75- X  25-mm glass slides covered with 2.5 ml of gel 
consisting of 0.4%  agarose in 0.01  M  Tris buffer containing 0.1%  sodium azide.  Reactants 
were placed in wells 5 mm in diameter and 3 mm apart, and the slides were incubated in moist 
chambers at room temperature. Results were read after 24 h. In the standard rho antigen test, 
20-#1 aliquots of samples were tested using a  1:4 dilution of the standard rabbit antiserum; 
the titer was expressed as the reciprocal of the highest antigen dilution giving a line of pre- 
cipitation which fused with the standard rho antigen-antibody precipitate. 
Immunoelectrophoresis.--The  micromethod described by Scheidegger  (6)  was used. 
Theta and Iota Rubella Antigens  (5).--The rho antigen standard also was used in immuno- 
diffusion tests for theta and iota rubella reactants. Identification of the specific precipitates was 
aided by the use of human anti-theta  serum and an iota standard antigen kindly provided by 
Dr. George Le Bouvier, Yale University School of Medicine. 
Identification  and  Titration  of C-Reactive Protein  (CRP) and Other Human Protei~s.--Im- 
munodiffusion tests were done in the same manner as those for rho antigen. Purified CRP and 
specific hyperimmune serum were purchased from Difco Laboratories, Detroit, Mich. Purified 
plasma proteins and  other specific  antisera, including some prepared in rabbits and goats 
against whole human serum, were obtained from Hyland Div, Travenol Laboratories, Inc, 
Costa Mesa, Calif. 
Partial Purification  of Rho from Infected  Tissue Culture Fluid and from Human Serum.-- 
100 ml of medium obtained from rubella infected Vero cells was concentrated 200ffold  by 
forced dialysis with Aquacide before fractionation. Human serum with a  high rho titer and 
obtained from a patient with rheumatoid arthritis was first concentrated 10-20-fold by pre- 
cipitation with 50% saturated ammonium suffate.  Each rho concentrate was dialyzed over° 
night against Tris buffer, reduced to a final volume of 0.5 ml with Aquacide, and layered over 
3 The standard antiserum was prepared by Dr. Harvey Liebhaber in this laboratory in the 
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a  15-50% (wt/wt) sucrose gradient prepared in Tris buffer. The gradient was spun at 35,000 
rpm for 16 h at 4°C in an SW 50.1 rotor. Twenty fractions were collected through the bottom 
of the tube and tested by immunodiffusion for rho. The positive fractions were then pooled, 
dialyzed against Tris buffer, concentrated to 0.5 ml by forced dialysis, and recentrifuged as 
described above except that a 15--30% sucrose gradient was used. Positive fractions were again 
pooled,  layered  over a  5 ml  12-65%  sucrose gradient prepared in Tris-buffered D20,  and 
centrifuged at 35,000 rpm for 48 h in an SW 50.1 rotor. The rho-positive fractions were pooled, 
dialyzed, and used for the determination of physicochemical properties of the antigen and for 
immunizing rabbits. 
Fractionation of Human Serum.--140 ml of serum obtained from a single donor with juvenile 
rheumatoid arthritis and an elevated rho titer was centrifuged (2,000 rpm, 20 min) and the 
supernate was dialyzed overnight against 0.0033 M  sodium phosphate buffer, pH  5.2.  The 
precipitate was collected by centrifugation, washed twice with the dialyzing buffer, and dis- 
solved in 2 ml of pH 8.5 Tris buffer containing 0.15 M  NaC1. The serum supernatant fraction 
was precipitated in stepwise fashion with increasing concentrations of  ammonium sulfate. 
Each mixture was stirred for 30 rain before centrifugation and each precipitate was washed 
two times with ammgnium sulfate at the concentration used for precipitation. 
Sedimentation Analyses.--Buoyant density was  determined  by sedimentation through a 
preformed CsCI gradient, 20-40% (wt/wt), for 48 h at 5°C. Fractions were collected through 
the bottom of the tube and the density of each fraction was determined from its refractive 
index. 
To estimate sedimentation coefficients, 0.2 ml of sample was layered on a  15-30% (wt/wt) 
sucrose gradient in Tris buffer and centrifuged in an SW 50 L rotor for 16 h at 5°C. Fractions 
collected through the bottom of the tube were assayed for rho activity. Heterophile antibody, 
19S, and measles convalescent antibody, 7S, were used as sedimentation markers in tubes run 
in parallel (7). 
Rubella Hemagglutination-Inhibiting Antibody.--Tests were done as described by Liebhaber 
(8) on 19S and 7S antibody fractions prepared by sucrose gradient centrlfugation as described 
previously (9). 
Fluorescent Antibody Staining.--Smears of normal or rubella virus infected Vero cells were 
prepared on glass slides.  The cells were fixed  in acetone at 20°C  for 3 rain. Rabbit anti-rho 
antiserum, human convalescent rubella serum, or other test serum described in the text was 
added and the slides were incubated at 37°C for 45 rain in a moist atmosphere. The slides were 
then thoroughly washed with phosphate-buffered saline (0.01 M  PO4,0.15 M  NaCI pH 7.2). 
Goat anfirabbit IgG or antihuman IgG globulin conjugated with fluoresceinisothiocyanate 
(Custom Reagent Lab., San Diego, Calif.) was  then added  for 45 min, 37°C.  Mter a second 
washing, the slides were examined using a Leitz fluorescence microscope. 
Serum Specimens.--The sera tested were obtained from several sources. Stored specimens 
from previous rubella investigations conducted in our laboratory provided the samples from 
normal children and adults, from patients in the acute phase of rubella, from virus-positive 
infants with the rubella syndrome, and from experimentally infected chimpanzees. 
Cord  sera were  obtained from normal infants.  Specimens were  obtained from pregnant 
women and from patients with rheumatoid arthritis, degenerative joint diseases, and lupus 
erythematosus. All the above were patients on the wards or in the clinics of Yale New Haven 
Hospital  and  West Haven Veterans Administration Hospital.  We  appreciate  the  help  of 
Dr.  Eric Knox, Dr.  Richard Lee, and Dr.  Ernest Kohorn in obtaining these sera. We are 
indebted to Dr. Alfred Evans and Dr. James Niederman of the World Health Organization 
Reference Serum Bank, Yale University School of Medicine, for additional normal sera col- 
lected from Yale University freshmen. Dr. Eric Nordenfelt of the University of Lund, Sweden, 
kindly provided specimens from hemophiliacs, and we  are grateful to Dr.  Charles Afford, 
University of Alabama, for cord sera from cases of c3ngenital eytomegalovirus infection. 500  NEW  ACUTE PHASE PROTEIN IN RUBELLA VIRUS INFECTION 
RESULTS 
A  Comparison of the Properties of Rho Isolated from Human Serum and from 
Rubdla Virus-Infected  Tissue Culture Medium.--The properties of rho antigen 
in serum from a  patient  with  rheumatoid  arthritis  and in fluids from rubella 
virus  infected  Vero  cells  were  compared.  The  antigens  had  been  partially 
purified by ammonium sulfate precipitation followed by two cycles of velocity 
sedimentation  and one sedimentation  to  approach  density equilibrium  before 
testing,  as described above. 
Antigenic  characteristics:  When the antigens  derived  from the  two sources 
were  tested  side-by-side  with  antisera  from  rabbits  immunized  with  rubella 
virus-associated antigen the precipitin lines fused, giving a reaction of identity 
(Fig.  1).  However, when the  antigens were tested  against  a  rabbit  antiserum 
prepared against rho obtained from human serum, a slight spur was noted. This 
result could indicate that the serum particle carrying the rho determinant  also 
contains a determinant not present on the antigenic particle produced in rubella 
virus-infected monkey tissue culture; it also could indicate the presence of an 
impurity.  The  latter  might contribute  to  the higher  sedimentation  coefficient 
found for serum rho as noted  below. 
All sara screened for rho antigen were also tested for rho antibody at the same 
time, since each serum was reacted with both the standard  antiserum  and the 
standard  antigen. We did not detect rho antibody in any of 306 early and late 
FIG. 1. Precipitin reactions between antigens from human sera or monkey ceils and anti- 
bodies against monkey cell-derived rho antigen. Ab-R1 and Ab-R2 are antisera  from rabbits 
immunized with rubella virus grown in monkey cells. Ag-H1  and Ag-H8 are rho-positive  human 
sara,  and  Ag-M is concentrated  medium from rubella  virus-infected monkey cell cultures. 
Ag-H2 is a rho-negative human serum. The second line seen between Ag-M and Ab-R1 is a 
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convalescent rubella sera. However, anti-rho antibodies were found in sera from 
3 of 18 rubella syndrome babies and also in the sera of 5 of 44 hemophiliacs. 
Electrophoretic  mobility  and relation  to recognized  plasma  proteins:  Antigen 
from both  sources  showed  identical  migration patterns  in  the  /3-1 region  as 
detected  by  immunoelectrophoresis.  When  human  serum-derived  rho  was 
electrophoresed  and  tested  against  antisera  prepared  against  homologous 
antigen  and  antigen from rubella-infected Vero cells their reaction lines met, 
showing  a  slight  spur,  again  suggesting  minor  antigenic  differences  or  the 
presence of an impurity (Fig. 2). 
FIO. 2. Immunoelectrophoresis  of rho antigen. The antigen was concentrated from human 
serum by dialysis against low ionic strength buffer as described in the  text. After electro- 
phoresis, antisera from rabbits immunized with rho derived from monkey cells, infected with 
rubella virus, or from human serum were added to the troughs. 
Antisera specific for a number of normal plasma proteins  4 and CRP as well, 
failed to react with rho in either the immunodiffusion or immunoelectrophoresis 
test.  Both  goat  and  rabbit  antihuman  serum  did  contain  anti-rho  activity, 
however. After absorption with rho-negative human serum, these hyperimmune 
sera  each  gave  a  single  line  of  precipitation  when  reacted  against  electro- 
phoresed concentrated rho-positive human serum. It should be emphasized that 
neither antihuman sera nor the standard rabbit anti-rho serum detected rho in 
electrophoresed human sera, unless the latter were of high titer (e.g., rheuma- 
4 Antisera to the following were tested: IgG, IgA, IgM, 3rd and 4th components of comple- 
ment, transferrin, haptoglobin, ~-lipoprotein, fibrinogen, orosomucoid, and a-2-macroglobulin. 502  NEW  ACUTE  PHASE  PROTEIN  IN  RUBELLA  VIRUS  INFECTION 
told arthritis sera)  and were  concentrated  three-to-fivefold before use. These 
results indicating the difficulty in detecting rho in human serum help to explain 
why rho has not to our knowledge been described before. 
Sedimentation  characteristics:  Estimates  of  the  sedimentation  coefficients 
were obtained  using  7S  and  19S  antibody markers.  Rho  from human  serum 
appeared  heterogeneous,  sedimenting  between  15  and  21S  (Table  I).  Rho 
obtained from tissue culture seemed more homogeneous and banded between 11 
and 14S. The role played by aggregation or disaggregation is not known. When 
sedimented for 48 h in CsC1 gradients, both antigens banded alike at a density 
of 1.31 g/ml. 
Stability:  As shown in Table I, antigen from both sources exhibited similar 
stability characteristics typical of proteins. 
TABLE I 
A  Comparison of the Characteristics of Rho Antigen Derived  from Rubella Virus-InfecteA Vero 
Cells and from Human Serum 
Human serum  Tissue culture 
Buoyant density 
Sedimentation coefficient 
Stability 
56°C, 60 min 
Acetone 33%, 4°C, 30 min 
Sodium deoxycholate 0.5%, 37°C, 1 h 
Sodium dodecyl sulfate 1.0%, 37°C, 1 h 
Trypsin 1%, 37°C, 1 h 
2-mercaptoethanol 0.5%, 37°C, 30 min 
pH 2, 22°C, 1 h 
1.305 g/ml  1.305 g/ml 
15-21S  11-14S 
+  + 
+  + 
+  + 
Solubility:  When serum was serially fractionated, over 50% of rho activity 
was  concentrated  by  overnight  dialysis  against  low  ionic  strength  buffer 
(Table II). The balance was recovered in the 33 % ammonium-sulfate fraction 
after stepwise precipitation of serum. 
In  Vitro Synthesis and Inhibition by A ctinomycin D.-- 
Intracdlular  localization  with  fluorescent  antibody:  Rubella  virus-infected 
and  uninfected  Veto  cells  were  examined  by  immunofluorescent  antibody 
staining to detect the presence of rho. An antihuman-derived the rabbit serum 
was used followed by fluorescein-conjugated  antirabbit  IgG. No fluorescence 
was seen in control cells at any time; in infected cells it did not appear until 2 
days after inoculation. At that time the antigen was revealed as tiny starlike 
points of fluorescence throughout the cytoplasm (Fig. 3 B). The cultures were 
examined daily for 1 wk postinfection, and the stained granulations gradually 
increased  in  size but  remained  small  and discrete.  The reaction was not in- 
hibited  by pretreatment of the cells with  rubella convalescent human serum 
which was used to demonstrate rubella-specific antigen in cultures infected at CAPPEL, SCHLUEDERBERG, GIFFORD, AND HORSTMANN  503 
TABLE  II 
Percentage  of Individual Human Serum Components  Recovered after Successive Precipitations 
with Ammonium Sulfate* 
Percent of recovered activity in  each precipitate 
Precipitation step  Beta- 
Rko  IgM  IgA  IgG  C'3  lipo- 
protein 
Albumin 
Dialysis against 0.0033 M Na+  52  64  3  5  3  6  < 1 
33% saturated  (NI-I4)SO4  48  10  20  80  43  11  1 
40% saturated (NH4)SO4  0  16  38  9  40  10  1 
50% saturated (NH4)SO4  0  10  38  4  10  20  2 
75% saturated (NH4)SO4  0  0  1  <1  3  53  96 
* The serum was obtained from an adult with juvenile rheumatoid arthritis; no rheumatoid 
factor was detectable by latex agglutination. 
the same time (Fig.  3 C). The rho-specific  reaction was inhibited  by an anti- 
human goat serum which had been absorbed with rho-negative human serum. 
This serum,  as noted in the section on electrophoretic properties of rho, was 
monospecific for rho by immunoelectrophoresis. 
E~ect of actinomycin  D:  As a further test of the host or viral origin  of rho 
in rubella virus-infected cultures,  experiments were set up to see if we could 
show a selective inhibition of rho in comparison with a rubella antigen. Veto cells 
were grown in roller bottles and infected with rubella virus. 4 days after inocula- 
tion,  at a  time when virus was being maximally produced,  the cultures were 
drained and fresh medium was added. One-half of the cultures received actino- 
mycin D  at  a  concentration  of 5.0/zg/ml  or 2.5/zg/ml,  depending  upon  the 
experiment (Table III). 24 h later the cultures were harvested and the levels of 
rho and of the rubella antigen, iota, were determined. The results show a greater 
reduction in rho titer than in iota fiter, providing additional evidence that rho 
may be an inducible host protein. 
In another experiment acfinomycin was added to cultures 48 h after infection 
when both rho and rubella antigens could be demonstrated intracellularly by 
immunofluorescence. Rho could not be detected after a 24 h  exposure to drug, 
whereas rubella-specific fuorescence appeared the same as in untreated control 
cultures. 
Production in virus-infected  cell cultures .from different  species:  Induction of 
rho by rubella virus was not limited to Vero cells (a monkey kidney line), but 
the virus induced  rho in pig kidney and BHK 21  hamster cells as well. Rho 
obtained from all these sources gave reactions of identity with the standard 
antiserum. However, the antigen could not be detected in uninfected cultures 
even when media were highly concentrated or when cell packs were repeatedly 
used in an attempt to absorb out rho antibodies. 
Concentrated  medium  from  cell  cultures  infected  with  herpes  simplex, 
measles, influenza,  parainfluenza,  or  SSPE  virus  did  not  contain  detectable FIG. 3. Intracellular localization of rho antigen by fuorescent antibody staining. A. Unin- 
fected Vero cells exposed to anti-rho  rabbit serum followed  by fluorescein-conjugated anti- 
rabbit IgG. B. Vero cells 48 h after infection with rubella virus and stained as in "A". C. Vero 
cells, 48 h  after infection with rubella virus, exposed to human rubella convalescent serum, 
followed by fluorescein-conjugated antihuman IgG. 
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TABLE III 
Effect of Actinomycin D on Yields of Rho and Iota Antigens in Rubella Virus-Infected Veto Cells 
24 h after Exposure to Drug 
Total Immunodiffusion  Units* 
Expt. 1~  Expt. 2§ 
Control  5  t*g/ml  Control  2.5/~g/ml  actinomycin  actinomycin 
Iota  120  80  800  400 
120  160  800  400 
Rho  60  20  3200  200 
60  20  1600  200 
* Total units =  titer )< volume of concentrate  )< 50. The results of two separate titrations 
are given. 
:~The medium was pooled with a frozen-thawed cell extract; three cultures per group. 
§ The medium alone was pooled; 16 cultures per group. 
levels of rho,  but two pools of fluids from Vero cells infected with adenovirus 
type 5 were shown to contain low levels of activity. 
Similarities between Rho and Acute Phase Proteins.--It is a well known obser- 
vation  that  in  the  course  of  viral  or  bacterial  infections,  chronic  diseases, 
pregnancy, or after body injuries,  the concentration of several plasma proteins 
is increased,  and that some new proteins, like CRP in man and a-2-globulin in 
rats,  become detectable in the blood. The latter  are often referred to as acute 
phase  proteins  (2).  The following results  document  the prevalence  of rho  in 
certain  disease  and  physiologic states,  and  indicate  the  patterns  of rise  and 
decline of rho in comparison with CRP after natural  and experimental  rubella 
virus infection. 
Rho  and  CRP  in  the  blood after  acute  rubella:  Serum  specimens  from  11 
young male recruits during 2 wk postrubella were available for testing. 5 Fig. 4 
shows that on the day of onset 8 patients had elevated rho titers, and CRP was 
detectable in sera from 10 of the men. The percent with elevated titers of both 
antigens  declined from the  2nd  day on,  while  antibodies  to rubella virus  in- 
creased in titer. 
Appearance of Rho and CRP in the blood of experimentally infected chimpanzees: 
Serum specimens collected from two chimpanzees  during  an earlier  study, in 
this  laboratory,  of  experimental  rubella  infection  and  reinfection  (10)  were 
titrated for rho  antigen and tested for the presence of CRP. The animals had 
been given live rubella virus by three different routes  at intervals of 4-10 mo 
as  shown in Fig.  5.  The  serologic findings  were  almost identical  for the  two 
animals,  but for simplicity the results  are shown only for one. After the first 
exposure, which was by virus feeding, no antibodies were detected and the only 
5 We are grateful to Maj. Donald M. Rosenberg, Medical Corps U. S. Army, for collecting 
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FIG. 4. Comparison of the clearance of rho and CRP after acute natural rubella infection: 
results on 11 patients. A. Percent with elevated titers of rho (_>2) and CRP by day after onset. 
B. Geometric mean rubella HAI antibody titers in 19S and 7S serum fractions. 
evidence that infection had taken place was provided by the isolation of virus 
from the throat and from the blood on a single day. When the sera were sub- 
sequently tested for rho activity, a clear rise and decline was found commencing 
on the  10th  day.  No  CRP  was detectable  during  the  4  wk postinocUlation 
period. When the animals were given virus by intravenous inoculation several 
months later, a typical rubella infection ensued with viremia and virus shedding 
from the throat,  followed by the appearance of rubella neutralizing,  comple- 
ment-fixing, and HAI antibodies. Rho and CRP were below threshold levels  in 
sera collected on the 6th day after inoculation, but both antigens were elevated 
in sera collected on day 10, and both were absent in specimens obtained after 
the 3rd wk. After intramuscular injection of live virus 8 mo later, no virus was 
isolated but  there  was a  boost in  antibody titer  and  a  prompt, possibly ac- 
celerated, response to both CRP and rho. 
Prevalence of rho:  Table IV shows the prevalence and geometric mean rho 
titers  in  a  preliminary  sampling  of sera  from  normal  newborns  and  adults, 
pregnant  women,  and  patients  with  chronic inflammatory disease.  Rho  was CAPPEL,  SCHLUEDERBERG,  GLFYORD, AND  HORSTMANN  507 
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FIG.  5.  Appearance of rho antigen in the blood after experimental rubella infection and 
reinfection in a chimpanzee.* The first virus exposure was by ingestion, the second by intra- 
venous inoculation, and the third by intramuscular injection. The indicated virus isolations 
were from blood specimens. 
detectable in 90% of newborn sera and titers were slightly elevated relative to 
adult controls. Of the groups tested, titers were most enhanced during preg- 
nancy and in rheumatoid arthritis. In these cases, 100 % of sera were positive, 
with geometric mean titers 5-7 times that of controls. The prevalence and titer 
of CRP is also shown, and while both antigens tend to be elevated in the same 
conditions, the correlation is not an invariable one. 
DISCUSSION 
We have presented evidence that rho is a protein antigen common to man 
and many mammals,  and that rubella virus infection and a number of other 
stimuli may induce its increased production. The antigen has been induced in 
monkey, hamster, and pig cells and it has been demonstrated in sera from in- 
fected baboons,  chimpanzees,  and from pregnant  rhesus  monkeys. Antigens 
from all these sources gave reactions of identity in immunodiffusion tests with 
antiserum to antigen induced in monkey kidney cells.  The spur noted when 
monkey and human-derived antigens were tested with a rabbit antiserum pre- 
pared  against  rho  from human  serum  may reflect slight  species-specific dif- 
ferences, or it may indicate the presence of impurities. When these experiments 
* The serologic picture was duplicated in a second animal. Complete details of inoculation 
procedures and other serologic results have been described (10). 508  NEW  ACUTE  PHASE PROTEIN IN RUBELLA  VIRUS INFECTION 
TABLE IV 
Serum Levels of Rho and CRP in Normal Humans and in Certain Disease States 
Source  Number  R~  CRP  CRP  tested  Age  positive  R/~  positive 
%  GMT*  %  GMT 
Normal adults  54  18-45  65  1.2  NT~  NT 
Normal cord  19  Newborn  90  1.5  NT  NT 
Pregnancy (2nd and 3rd tri-  24  14-37  100  5.2  77  3.3 
mester) 
Acute Rubella (15 days postonset)  31  25-30  96  3.7  30  1.0 
Acute adenovirus infection  (Un-  12  --  92  1.6  NT  NT 
typed, 7-14 days postonset) 
Congenital rubella  17  Newborn  94  4.8  NT  NT 
Congenital cytomegalovirus  24  Newborn  100  3.2  NT  NT 
infection 
Rheumatoid arthritis-active  12  41-74  100  8.3  90  5.6 
inactive  10  44-72  100  3.6  51  4.6 
Lupus erythematosus  15  14-35  93  2.0  20  2.6 
Other diseases of the joints§  9  22-65  66  1.1  66  2.6 
Hemophilia  44  --  88  2.4  43  NT 
* Geometric mean titer of positive specimens. 
~: Not tested. 
§ Ankylosing  spondylitis (1), psoriatic arthritis (2), gout (3), dermatomyositis (1), chondro- 
calcinosis (1). 
were  repeated  with  antigens  purified  by  column  chromatography  and  with 
different rabbit antisera, no spur formation was seen. ~ 
It might  be concluded that the goat and rabbit lack normal  cross-reactive 
rho antigens, since no antigen was detectable in normal sera from these animals 
and antibodies were raised after injection of rho from other  species.  However, 
we do not know the effects of the adjuvant present in the immunizing prepara- 
tion,  nor  of  hyperimmunization  on  immune  recognition  in  this  case.  The 
presence of rho antibodies in sera from multiply transfused persons with hemo- 
philia  and  in  persistently  infected  rubella  syndrome  babies  indicates  that 
hyperimmunization may induce  an immune  response  even  to  autologous rho 
antigen. 
The possibility that rubella virus also codes for a  cross-reacting antigen was 
considered, since rho was produced in normally negative cell cultures in amounts 
similar to the rubella-specific antigens theta and iota after virus infection, and it 
was difficult to dissociate the antigen from  the virus during purification. The 
experiments  using  actinomycin D  coupled  with  those  comparing  the  virus- 
induced and  rheumatoid  arthritis-induced proteins provided evidence that in 
6 Liebhaber, Harvey. Manuscript in preparation. Purified antigen also failed to precipitate 
when dialyzed against water, indicating that the antigen may not be an euglobulin as was sug- 
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the in vitro rubella system, too, rho is specified by the cell and not by the virus. 
This conclusion received firm support when it was shown that adenovirus also 
induced rho in Vero cells. Thus, an excellent new model is now available for the 
study of virus-induced cell genome expression. 
When the dynamics of increase and decline of rho were compared with that 
of CRP in the blood of rubella patients and chimpanzees infected with the virus, 
similar but not identical patterns were found, and both were already elevated 
in the majority of patients at the time of onset of disease. The sensitivity of 
rho  as an indicator of response to  an infectious agent was illustrated by its 
appearance in two chimpanzees given rubella virus orally. There was no other 
serologic evidence of infection in these animals, but the virus was isolated from 
the blood and throat of one of them on day 6 postinoculation. Neither animal 
showed a CRP response nor an antibody response after ingestion of the virus. 
On  subsequent  intravenous inoculation of  the  virus,  both  chimpanzees  de- 
veloped subclinical infections; they demonstrated viremia, virus shedding from 
the throat, and developed rubella antibody responses which, in time-course and 
magnitude, indicated that the animals had not been primed by the first exposure. 
It may be that following the first exposure, rho was an indicator of rubella virus 
activity too weak even to have stimulated the animals immunologically. After 
the third exposure to rubella virus, some 10 mo after the second, there was a 
prompt increase in both rho  and CRP in the blood. The rapid appearance at 
this time was most likely a reflection of anamnestic immune response rather 
than of viral multiplication, since Wood has shown that the level of CRP may 
reflect the  intensity of immune  response  (11).  Both mechanisms  may have 
played a role, however. 
We were not able to show a relationship between rho and previously described 
normal human proteins which migrate in the/~-1 or a-2 regions during electro- 
phoresis. Despite the fact that rho may have a functional relationship to CRP, 
they are different chemically and physically as well as antigenically (12,  13). 
Rho  appeared to have a number of properties in common with another acute 
phase protein, however, viz., the a-2-globulin of the rat (14). When these two 
antigens were compared by immunodiffusion, no cross reactivity was foundJ 
Whether rho  has been recognized in man before and given another name is 
uncertain, but we know of no report of a particular antigenic species like rho 
that is recognized as an acute phase protein. The unusual set of circumstances 
that provided us with the necessary specific antisera, and the low levels of rho 
in human serum help to explain this gap. 
S~ARY 
A precipitating antigen, rho,  was first detected in the blood of persons with 
rubella and in rubella virus-infected cell culture fluids (1). Partially purified 
z We are grateful to Dr. Edward J. Sarcione, Roswell Park Memorial Institute, who did 
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antigens from both sources were examined  and  shown  to have similar prop- 
erties,  although  antigen  from serum  sedimented  more heterogeneously,  with 
estimated  coefficients  from  15  to  21 S,  while  that  from  culture  fluids  sedi- 
mented in the 11-14 S region. In each case, antigen was located in the 8-1 zone 
after electrophoresis in agarose, and at a density of 1.305 g/ml after centrifuga- 
tion in CsC1. Stability characteristics were typical of protein antigens. 
Immunofluorescent microscopy revealed that rubella virus induced  the  ap- 
pearance of rho antigen scattered throughout the cytoplasm of infected cells. 
When cells containing antigen were exposed for 24 h to 5/zg/ml actinomycin D 
rho  was  no  longer  detectable,  indicating  the  probable  cellular  origin  of  the 
antigen.  Also, titers in medium of infected cultures showed a  reduction  after 
actinomycin  treatment,  but  levels  of  the  virus-specified  antigen,  iota,  were 
relatively unaffected. 
Rho appears to be a protein common to man and many animals. In vitro, it 
was induced by rubella virus and by adenovirus. In vivo, rho titers were shown 
to be elevated after rubella virus infection and, to a lesser extent, after infection 
with certain other viruses. High titers were also demonstrated in women late in 
pregnancy and in patients with rheumatoid arthritis. In man and the chimpan- 
zee, the  appearance and decline of rho in the blood after rubella virus infection 
were temporally similar to the patterns of CRP, although rho seemed to be a 
more sensitive indicator of infection. 
The  data  presented  indicate  that  rho  is  a  newly  recognized  acute  phase 
protein inducible by certain virus infections and by other unidentified stimuli 
present prominently in pregnancy and rheumatoid arthritis. 
We wish to thank Mrs. Brigitte Evans, Mrs. Lucy Gimpel,  and Miss Cynthia Neumann for 
excellent technical assistance. 
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